This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Warner Chilcott gets US rights to Novartis' Enablex
30 Sep 2010
Novartis AG has granted Warner Chilcott PLC (primarily dermatology, women's health, gastrointestinal, and muscloskeletal conditions) exclusive US marketing rights to Enablex (darifenacin) extended-release tablets for adults with symptoms of an overactive bladder, which include urge urinary incontinence, urgency, and frequency.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?